Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06506929 · ClinicalTrials.gov registry record · NA

Task Specific Training for Advanced Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Hunter College of City University of New York.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06506929 is a NA study of Multiple Sclerosis that is actively recruiting participants, run by Hunter College of City University of New York. The registered enrollment target is 15 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06506929, a NA study of Multiple Sclerosis, is actively recruiting participants, sponsored by Hunter College of City University of New York.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find effective physical therapy treatments for individuals who have severe multiple sclerosis. Physical therapy treatments for mild-to-moderate multiple sclerosis exists, however, very limited research has been done for physical therapy for severe multiple sclerosis (MS). In this study 10 participants diagnosed with severe MS will engage in 1-hour physical therapy sessions twice a week for 6 weeks to address limitations in standing, balancing, and bed mobility.

Conditions Studied

Interventions

  • OTHER Task specific physical therapy

Study Locations (1)

New York

  • Hunter College, Physical Therapy Department, City University of New York - New York

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2024-07-10
Est. Completion 2026-01
Phase NA

What the Registry Record Tells You About NCT06506929

The ClinicalTrials.gov registry entry for NCT06506929 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is Hunter College of City University of New York, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Task specific physical therapy is the first listed.

NCT06506929 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06506929 about?

NCT06506929 is a clinical study titled "Task Specific Training for Advanced Multiple Sclerosis". The purpose of this study is to find effective physical therapy treatments for individuals who have severe multiple sclerosis. Physical therapy treatments for mild-to-moderate multiple sclerosis exists, however, very limited research has been done for physical therapy for severe multiple sclerosis (...

What is the current status of trial NCT06506929?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-07-10. Estimated completion is 2026-01.

What conditions does trial NCT06506929 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT06506929?

The interventions under investigation include: Task specific physical therapy (OTHER).

Who is sponsoring clinical trial NCT06506929?

This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06506929 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.